A Chlamydia Vaccine May Be Getting Closer
A potential vaccine for our most common sexually transmitted infection has passed an important early test on the road to availability.
A new needle-free flu vaccine patch revved up the immune system much like a traditional flu shot without any negative side effects. The research represents an important step toward a technology that could replace needle-based vaccination methods that are difficult to deploy in developing countries.
Condition: Herpes Zoster Interventions: Biological: Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A); Drug: Placebo Sponsor: GlaxoSmithKline Not yet recruiting
Condition: Respiratory Syncytial Virus Infections Interventions: Biological: RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B; Drug: Placebo Sponsor: GlaxoSmithKline Not yet recruiting
Conditions: Castration-resistant Prostate Cancer; Metastatic Cancer; Prostate Cancer Interventions: Biological: pTVG-HP; Biological: pTVG-AR; Drug: Pembrolizumab; Drug: rhGM-CSF Sponsors: University of Wisconsin, Madison; Merck Sharp & Dohme Corp.; Madison Vaccines, Inc; Prostate Cancer Foundation Not yet recruiting
Condition: Burns Interventions: Device: NovoSorb BTM; Procedure: Standard of Care Sponsor: PolyNovo Biomaterials Pty Ltd. Not yet recruiting
Authors: Floret D Abstract THE DEVELOPMENT OF VACCINATION POLICY: In France, the minister of health is responsible for vaccination policy. Its development is based on the expertise of a Technical Committee on Vaccinations, attached to the High Authority of Health (HAS). The Committee's main missions are to issue recommendations and propose updates to the vaccination calendar. Its composition guarantees multidisciplinary expertise by integrating professionals interested in vaccination who must not have any conflict of interest. A response to referrals, usually from the Directorate-General for Health, is made accordi...
By JOE FLOWER The system is unstable. We are already seeing the precursor waves of massive and multiple disturbances to come. Disruption at key leverage points, new entrants, shifting public awareness and serious political competition cast omens and signs of a highly changed future. So what’s the frequency? What are the smart bets for a strategic chief financial officer at a payer or provider facing such a bumpy ride? They are radically different from today’s dominant consensus strategies. In this five-part series, Joe Flower lays out the argument, the nature of the instability, and the best-bet strategie...
Authors: López de Munain J PMID: 31519370 [PubMed - as supplied by publisher]
CDC guidelines leave it up to physicians to talk about the optional vaccine. But not all doctors do.
GIDEON what’s new summary: September 14 to September 16, 2019 Infectious Diseases – Outbreaks (25 updates) 25 DiseasesMap Infectious Diseases – Diseases (81 updates) 32 Diseases49 Country notesMap Infectious Diseases – Vaccines (1 updates) 1 Vaccine The post Update: September 16, 2019 appeared first on GIDEON - Global Infectious Diseases and Epidemiology Online Network.